NYSE:CNMD CONMED (CNMD) Stock Forecast, Price & News $132.56 +0.88 (+0.67%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$128.96▼$132.5950-Day Range$115.75▼$131.6852-Week Range$71.09▼$133.13Volume323,862 shsAverage Volume388,601 shsMarket Capitalization$4.05 billionP/E RatioN/ADividend Yield0.60%Price Target$130.40 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability CONMED MarketRank™ ForecastAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside1.6% Downside$130.40 Price TargetShort InterestBearish13.44% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-0.74Upright™ Environmental ScoreNews Sentiment0.37Based on 8 Articles This WeekInsider TradingSelling Shares$8.76 M Sold Last QuarterProj. Earnings Growth26.39%From $3.41 to $4.31 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.63 out of 5 starsMedical Sector827th out of 987 stocksElectromedical Equipment Industry18th out of 22 stocks 1.4 Analyst's Opinion Consensus RatingCONMED has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $130.40, CONMED has a forecasted downside of 1.6% from its current price of $132.56.Amount of Analyst CoverageCONMED has only been the subject of 2 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted13.44% of the outstanding shares of CONMED have been sold short.Short Interest Ratio / Days to CoverCONMED has a short interest ratio ("days to cover") of 11, which indicates bearish sentiment.Change versus previous monthShort interest in CONMED has recently increased by 3.79%, indicating that investor sentiment is decreasing. Previous Next 0.8 Dividend Strength Dividend YieldCONMED has a dividend yield of 0.63%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCONMED does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, CONMED will have a dividend payout ratio of 18.56% next year. This indicates that CONMED will be able to sustain or increase its dividend. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCONMED has received a 64.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Surgical instruments", "Medical technology engineering", and "Training for medical professionals" products. See details.Environmental SustainabilityThe Environmental Impact score for CONMED is -0.74. Previous Next 2.4 News and Social Media Coverage News SentimentCONMED has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for CONMED this week, compared to 4 articles on an average week.MarketBeat Follows2 people have added CONMED to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CONMED insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,761,613.00 in company stock.Percentage Held by InsidersOnly 7.60% of the stock of CONMED is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for CONMED are expected to grow by 26.39% in the coming year, from $3.41 to $4.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CONMED is -40.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CONMED is -40.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCONMED has a PEG Ratio of 1.94. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCONMED has a P/B Ratio of 5.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About CONMED (NYSE:CNMD) StockCONMED Corp. operates as a medical technology company, which engages in the development, manufacturing, and sale of surgical devices and related equipment. It operates through the United States, Europe, Middle East, and Africa, and Asia Pacific geographical segments. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.Read More Receive CNMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. Email Address CNMD Stock News HeadlinesJune 6, 2023 | americanbankingnews.comReviewing Outset Medical (NASDAQ:OM) and CONMED (NYSE:CNMD)June 5, 2023 | americanbankingnews.comBrokerages Set CONMED Co. (NYSE:CNMD) Price Target at $130.40June 9, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 24, 2023 | americanbankingnews.comCONMED Co. (NYSE:CNMD) VP Stanley W. Peters III Sells 1,500 Shares of StockMay 24, 2023 | americanbankingnews.comCL King Initiates Coverage on CONMED (NYSE:CNMD)May 23, 2023 | americanbankingnews.comHead-To-Head Contrast: CONMED (NYSE:CNMD) vs. BioSig Technologies (NASDAQ:BSGM)May 19, 2023 | seekingalpha.comConmed: Updated Guidance Is PositiveMay 17, 2023 | americanbankingnews.comReviewing CONMED (NASDAQ:CNMD) & Viveve Medical (NASDAQ:VIVE)June 9, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...May 14, 2023 | americanbankingnews.comCritical Review: ViewRay (NASDAQ:VRAY) vs. CONMED (NASDAQ:CNMD)May 12, 2023 | americanbankingnews.comCritical Comparison: CONMED (NASDAQ:CNMD) versus Guided Therapeutics (OTCMKTS:GTHP)May 11, 2023 | americanbankingnews.comBrokerages Set CONMED Co. (NYSE:CNMD) Price Target at $128.00May 9, 2023 | americanbankingnews.comCONMED Co. to Post FY2023 Earnings of $3.33 Per Share, Zacks Research Forecasts (NYSE:CNMD)May 5, 2023 | americanbankingnews.comQ2 2023 Earnings Estimate for CONMED Co. Issued By Zacks Research (NYSE:CNMD)May 5, 2023 | americanbankingnews.comCONMED Co. (NYSE:CNMD) EVP Sells $312,576.00 in StockMay 4, 2023 | americanbankingnews.comInsider Selling: CONMED Co. (NYSE:CNMD) VP Sells 24,017 Shares of StockMay 3, 2023 | americanbankingnews.comBrian Concannon Sells 2,072 Shares of CONMED Co. (NYSE:CNMD) StockMay 3, 2023 | americanbankingnews.comDaniel S. Jonas Sells 10,000 Shares of CONMED Co. (NYSE:CNMD) StockMay 2, 2023 | americanbankingnews.comCONMED Co. (NYSE:CNMD) Forecasted to Earn FY2023 Earnings of $3.40 Per ShareApril 30, 2023 | americanbankingnews.comNeedham & Company LLC Raises CONMED (NYSE:CNMD) Price Target to $135.00April 29, 2023 | americanbankingnews.comCONMED (NASDAQ:CNMD) Upgraded to "Hold" at StockNews.comApril 29, 2023 | americanbankingnews.comCONMED (NYSE:CNMD) Trading Up 6.9% After Strong EarningsApril 28, 2023 | americanbankingnews.comCONMED (NYSE:CNMD) Price Target Increased to $130.00 by Analysts at Stifel NicolausApril 28, 2023 | americanbankingnews.comCONMED (NYSE:CNMD) Given New $128.00 Price Target at Piper SandlerApril 28, 2023 | americanbankingnews.comCONMED (NYSE:CNMD) Price Target Raised to $119.00 at Wells Fargo & CompanyApril 28, 2023 | americanbankingnews.comAnalysts Issue Forecasts for CONMED Co.'s Q3 2023 Earnings (NYSE:CNMD)April 28, 2023 | americanbankingnews.comCONMED Co. (NYSE:CNMD) to Post Q2 2023 Earnings of $0.80 Per Share, Jefferies Financial Group ForecastsSee More Headlines CNMD Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNMD Company Calendar Ex-Dividend for 4/5 Dividend3/14/2023Dividend Payable4/05/2023Last Earnings4/26/2023Today6/09/2023Ex-Dividend for 7/5 Dividend6/14/2023Dividend Payable7/05/2023Next Earnings (Estimated)7/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNYSE:CNMD CUSIPN/A CIK816956 Webwww.conmed.com Phone(727) 392-6464Fax315-797-0321Employees4,100Year FoundedN/APrice Target and Rating Average Stock Price Forecast$130.40 High Stock Price Forecast$140.00 Low Stock Price Forecast$119.00 Forecasted Upside/Downside-1.5%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($3.25) Trailing P/E RatioN/A Forward P/E Ratio38.84 P/E Growth1.94Net Income$-80,580,000.00 Net Margins-8.53% Pretax Margin-7.82% Return on Equity11.38% Return on Assets3.66% Debt Debt-to-Equity Ratio1.32 Current Ratio1.90 Quick Ratio0.86 Sales & Book Value Annual Sales$1.10 billion Price / Sales3.69 Cash Flow$5.41 per share Price / Cash Flow24.49 Book Value$24.46 per share Price / Book5.41Miscellaneous Outstanding Shares30,575,000Free Float28,251,000Market Cap$4.05 billion OptionableOptionable Beta1.38 Key ExecutivesCurt R. HartmanChairman, President & Chief Executive OfficerTodd W. GarnerChief Financial Officer & Executive Vice PresidentShanna L. Cotti-OsmanskiChief Information Officer & Executive VP-ITTerence M. BergéVice President & ControllerBill Peters PetersVice President & General Manager-Advanced SurgicalKey CompetitorsInModeNASDAQ:INMDIntegerNYSE:ITGRTransMedics GroupNASDAQ:TMDXLivaNovaNASDAQ:LIVNOutset MedicalNASDAQ:OMView All CompetitorsInsiders & InstitutionsBrian ConcannonSold 812 sharesTotal: $104,756.12 ($129.01/share)Macquarie Group Ltd.Bought 17,968 shares on 6/1/2023Ownership: 2.495%ProShare Advisors LLCSold 126 shares on 5/26/2023Ownership: 0.015%Mountain Pacific Investment Advisers Inc. IDBought 4,878 shares on 5/23/2023Ownership: 0.426%Ameriprise Financial Inc.Bought 99,568 shares on 5/22/2023Ownership: 4.418%View All Insider TransactionsView All Institutional Transactions CNMD Stock - Frequently Asked Questions Should I buy or sell CONMED stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CNMD shares. View CNMD analyst ratings or view top-rated stocks. What is CONMED's stock price forecast for 2023? 4 analysts have issued 12-month target prices for CONMED's shares. Their CNMD share price forecasts range from $119.00 to $140.00. On average, they expect the company's share price to reach $130.40 in the next twelve months. This suggests that the stock has a possible downside of 1.5%. View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts. How have CNMD shares performed in 2023? CONMED's stock was trading at $88.64 at the beginning of the year. Since then, CNMD stock has increased by 49.4% and is now trading at $132.44. View the best growth stocks for 2023 here. When is CONMED's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023. View our CNMD earnings forecast. How were CONMED's earnings last quarter? CONMED Co. (NYSE:CNMD) released its quarterly earnings data on Wednesday, April, 26th. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.06. The business earned $295.47 million during the quarter, compared to analysts' expectations of $266.66 million. CONMED had a negative net margin of 8.53% and a positive trailing twelve-month return on equity of 11.38%. The company's revenue for the quarter was up 21.9% on a year-over-year basis. During the same period last year, the company earned $0.70 EPS. How often does CONMED pay dividends? What is the dividend yield for CONMED? CONMED announced a quarterly dividend on Wednesday, May 24th. Stockholders of record on Thursday, June 15th will be given a dividend of $0.20 per share on Wednesday, July 5th. This represents a $0.80 annualized dividend and a yield of 0.60%. The ex-dividend date is Wednesday, June 14th. Read our dividend analysis for CNMD. What ETFs hold CONMED's stock? ETFs with the largest weight of CONMED (NYSE:CNMD) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), Small Cap US Equity Select ETF (RNSC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Xtrackers S&P SmallCap 600 ESG ETF (SMLE), SPDR S&P SmallCap 600 ESG ETF (ESIX), BlackRock Future Health ETF (BMED) and iShares S&P Small-Cap 600 Value ETF (IJS). Is CONMED a good dividend stock? CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.63%. Read our dividend analysis for CNMD. What guidance has CONMED issued on next quarter's earnings? CONMED issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of $3.30-$3.50 for the period, compared to the consensus estimate of $3.32. The company issued revenue guidance of $1.21 billion-$1.25 billion, compared to the consensus revenue estimate of $1.19 billion. What is CONMED's stock symbol? CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD." Who are CONMED's major shareholders? CONMED's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.09%), Ameriprise Financial Inc. (4.42%), State Street Corp (3.81%), Champlain Investment Partners LLC (3.22%), Principal Financial Group Inc. (2.61%) and Macquarie Group Ltd. (2.50%). Insiders that own company stock include Brian Concannon, Daniel S Jonas, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III and Todd W Garner. View institutional ownership trends. How do I buy shares of CONMED? Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CONMED's stock price today? One share of CNMD stock can currently be purchased for approximately $132.44. How much money does CONMED make? CONMED (NYSE:CNMD) has a market capitalization of $4.05 billion and generates $1.10 billion in revenue each year. The company earns $-80,580,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. How many employees does CONMED have? The company employs 4,100 workers across the globe. How can I contact CONMED? CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321. This page (NYSE:CNMD) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.